Display:
My previous job was at a small software company selling software for biotech labs. Among other things, for tracing of experiments, QA, and establishing proven dates for IP protection.
One important part of the budget for big-business drug development, is the delirial risk-aversion of occidental societies.
Drugs are over-tested, requirements for the ratio of effectiveness to adverse effects are crazy, and the big pharma takes accordingly big measures to guarantee they will have no legal liabilities for new products (see the Vioxx law suits). Aspirin couldn't be released to the market if it was invented today.
The former (and much contested) manager of the Pasteur Institute in Paris, Philippe Kourilsky, also argued that our "ethic" standards were also hindering developed countries: we stopped the development of cost-effective drugs because they had adverse effects that the florida widows would deem unacceptable, when these effects wouldn't be noticed by a malaria-infected kid in Africa.
So basically, we have become a society of old coward farts. May be a great civilization collapse would do us good ...

Pierre
by Pierre on Fri Sep 22nd, 2006 at 06:02:46 AM EST
[ Parent ]
Yes, I agree we're too comfortable in our opulence.

Those whom the Gods wish to destroy They first make mad. — Euripides
by Migeru (migeru at eurotrib dot com) on Fri Sep 22nd, 2006 at 06:06:02 AM EST
[ Parent ]
life-style drugs for the rich vs life-saving drugs for the poor indeed.

Remember the big pharmas sued the states that tried to copy life-saving drugs and are still doing so.

by Laurent GUERBY on Fri Sep 22nd, 2006 at 07:44:41 AM EST
[ Parent ]
Who pays the bill for drug clinical tests? Are drug companies really paying 100% of the cost? Or is it us through insurance and government support?

Also, aren't clinical tests indeed much more expensive for lifestyle drugs involving 5% better chance of this or that than life-saving drugs were you die if you don't take it anyway?

And I don't buy the aspirin argument, there was a somewhat recent large trial of people taking aspirin all day long, so obviously it would have been accepted today.

For Vioxx, it is established that the company deliberately withdrew critical data from the regulator, this is an horrible crime, nothing to do with the discussion here.

Last point, big pharmas will always prefer drugs you have to take until the end of your life rather than drugs that cure you. Economics 101, but often forgotten, another ill-effect of the current screwed-up IP system.

by Laurent GUERBY on Fri Sep 22nd, 2006 at 07:43:03 AM EST
[ Parent ]
The bill is really for the big pharma, at least directly. Most of the "research" budget is actually big IT and staff spending to monitor the large scale trials. There are special contractors called CRO's "contract research organizations" who make a living on outsourcing this work.
Of course, since it's labeled "research", it can be partly funded by govn'mt funds for supporting research. In the EC, by Esprit/PCRD programs.

And I maintain that the FDA or EMEA criteria for safety are the same whether the drug is life saving or not. It is absolutely Kafkaian. For some "orphan" disease, they require proving the effect with double-blind trials involving more patients than you can enroll in a country the size of France, simply because there are too few people affected (they are now thinking about changing the workflow for those diseases...). And for drugs that only matter to the developing countries, they require proving that there are no interactions with prescription drugs for rich-world-only diseases.

The major preoccupation of the legislators and managers of approval agencies, is their own judicial security. So they build rules that nothing new can pass. They don't care for stuff that was approved before they took office: studies regarding aspirin are usually made by universities (big pharma doesn't pay to study public domain stuff) and since the universities have no hard cash, they make so-called meta-studies. By aggregating several other published studies primarily concerning other issues, but where patients were asked "do you regularly take aspirin", they can make findings by correlation which have a decent statistical meaning.

And if you look up most medical advisory text today, you really get a feeling that most physicians want to phase out aspirin because of oh-so-bad hemorraegic effects and stomach ulcers and-so-on...

Pierre

by Pierre on Fri Sep 22nd, 2006 at 10:21:34 AM EST
[ Parent ]

Display:
Login
. Make a new account
. Reset password
Occasional Series